40708-36-9Relevant academic research and scientific papers
INHIBITORS OF BRUTON'S TYROSINE KINASE
-
Paragraph 00990, (2016/12/22)
Disclosed herein are reversible and irreversible inhibitors of Bruton's tyrosine kinase (Btk). Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are describeded, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
4-amino(alkyl)cyclohexane-1-carboxamide compound and use thereof
-
, (2008/06/13)
4-Amino(alkyl)cyclohexane-1-carboxamide compounds of the formula (I) STR1 wherein each symbol is as defined in the Specification, isomers thereof and pharmaceutically acceptable acid addition salts thereof. The 4-amino(alkyl)cyclohexane-1-carboxamide comp
